Regulon

Regulon: R-1699

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
192.10526118Pr-131Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
1495 ENSG00000044115 CTNNA1 E5RGS1
6400 ENSG00000071537 SEL1L Q9UBV2
334 ENSG00000084234 APLP2 Q06481
3717 ENSG00000096968 JAK2 O60674
3312 ENSG00000109971 HSPA8 A8K7Q2
10728 ENSG00000110958 PTGES3 Q15185
1452 ENSG00000113712 CSNK1A1 P48729
523 ENSG00000114573 ATP6V1A P38606
5052 ENSG00000117450 PRDX1 Q06830
5782 ENSG00000127947 PTPN12 Q05209
6272 ENSG00000134243 SORT1 Q99523
3915 ENSG00000135862 LAMC1 P11047
8826 ENSG00000140575 IQGAP1 P46940
5899 ENSG00000144118 RALB P11234
56929 ENSG00000145780 FEM1C Q96JP0
5051 ENSG00000158006 PAFAH2 Q99487
5571 ENSG00000181929 PRKAG1 P54619
2342 ENSG00000257365 FNTB P49356
8754 ENSG00000282230 ADAM9 Q13443

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
RUXOLITINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor41
PACRITINIBFLT3Small moleculeINHIBITORTyrosine-protein kinase receptor FLT3 inhibitor30
LONAFARNIBFNTASmall moleculeINHIBITORProtein farnesyltransferase inhibitor41
IZENCITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor20
TOFACITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor40
GANDOTINIBJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
RUXOLITINIB PHOSPHATEJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
PEFICITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor30
FORIGERIMODHSPA8ProteinINHIBITORHeat shock cognate 71 kDa protein inhibitor30
TIPIFARNIBFNTASmall moleculeINHIBITORProtein farnesyltransferase inhibitor32
LESTAURTINIBJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor30
AC-430JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor10
MOMELOTINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor30
NS-018JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
BARICITINIBJAK1Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
BMS-911543JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
UPADACITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor40
FEDRATINIB HYDROCHLORIDEJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40
ZOTIRACICLIBCDK9Small moleculeINHIBITORCyclin-dependent kinase 9 inhibitor11
TOFACITINIB CITRATEJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor40
FORIGERIMOD ACETATEHSPA8ProteinINHIBITORHeat shock cognate 71 kDa protein inhibitor30
GUSACITINIBSYKSmall moleculeINHIBITORJanus Kinase (JAK) inhibitor20
XL-019JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor10
AZD-1480JAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor20
DELGOCITINIBJAK1Small moleculeINHIBITORJanus Kinase (JAK) inhibitor30
OCRIPLASMINLAMA2EnzymePROTEOLYTIC ENZYMEFibronectin proteolytic enzyme40
AT-9283AURKBSmall moleculeINHIBITORTyrosine-protein kinase JAK3 inhibitor20
FEDRATINIBJAK2Small moleculeINHIBITORTyrosine-protein kinase JAK2 inhibitor40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1699

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-01248RNF168down-regulatesHOXB8repressesR-169972Drugs (28)
CMF-01550CACNA1Bdown-regulatesHOXB8repressesR-169971Drugs (28)
CMF-02660LRRC66down-regulatesHOXB8repressesR-169971Drugs (28)
CMF-02983HFM1down-regulatesHOXB8repressesR-169972Drugs (28)
CMF-03892DSPdown-regulatesHOXB8repressesR-169974Drugs (28)
CMF-04860NEFMdown-regulatesHOXB8repressesR-169971Drugs (28)
CMF-07798GPR45down-regulatesHOXB8repressesR-169971Drugs (28)
CMF-08802FBLN2down-regulatesHOXB8repressesR-169972Drugs (28)
CMF-09076FLT1up-regulatesHOXB8repressesR-169971Drugs (28)
CMF-11198NRKdown-regulatesHOXB8repressesR-169972Drugs (28)
CMF-13510FMN1down-regulatesHOXB8repressesR-169974Drugs (28)
CMF-15420DSEdown-regulatesHOXB8repressesR-169973Drugs (28)
CMF-17393TBC1D8down-regulatesHOXB8repressesR-169972Drugs (28)
CMF-18227CDH19down-regulatesHOXB8repressesR-169974Drugs (28)
CMF-21904PRAMEdown-regulatesHOXB8repressesR-169971Drugs (28)
CMF-24800HIST1H2BEdown-regulatesHOXB8repressesR-169971Drugs (28)
CMF-27041DNAH5down-regulatesHOXB8repressesR-169972Drugs (28)
CMF-31053PNPLA7down-regulatesHOXB8repressesR-169972Drugs (28)